Dawa za Matibabu ya Ugonjwa wa Ateri ya Moyo

NaRanya N. Sweis, MD, MS, Northwestern University Feinberg School of Medicine;
Arif Jivan, MD, PhD, Northwestern University Feinberg School of Medicine
Imepitiwa/Imerekebishwa Feb 2024

    The heart muscle needs a constant supply of oxygen-rich blood. The coronary arteries, which branch off the aorta just after it leaves the heart, deliver this blood. Coronary artery disease that narrows one or more of these arteries can block blood flow, causing chest pain (angina) or an acute coronary syndrome (see also Overview of Coronary Artery Disease).

    In an acute coronary syndrome, sudden blockage in a coronary artery greatly reduces or cuts off the blood supply to an area of the heart muscle (myocardium). The lack of blood supply to any tissue is termed ischemia. If the supply is greatly reduced or cut off for more than a few minutes, heart tissue dies. A heart attack, also termed myocardial infarction (MI), is death of heart tissue due to ischemia.

    There are many different reasons doctors give medications to people with coronary artery disease:

    • To relieve chest pain by reducing the heart's workload and widening arteries (usually nitrates)

    • To prevent angina and acute coronary symptoms from occurring (beta-blockers, calcium channel blockers, and sometimes ranolazine)

    • To prevent and reverse coronary artery narrowing from atherosclerosis (angiotensin-converting enzyme [ACE] inhibitors, angiotensin II receptor blockers [ARBs], statins, and antiplatelet medications)

    • To open a blocked artery (clot-dissolving medications, anticoagulants)

    Often, oxygen is given through nasal prongs or a face mask. Providing more oxygen to the heart can help keep heart tissue damage to a minimum.

    Jedwali
    Jedwali

    Nitrati

    Most people are given nitroglycerin, which relieves pain by lowering blood pressure, which reduces the workload of the heart, and possibly by dilating arteries. Usually, it is first given under the tongue, then intravenously.

    Mofini

    Most people who have had a heart attack are experiencing severe discomfort and anxiety. Morphine has a calming effect and reduces the workload of the heart. It is given when nitroglycerin cannot be used or is not effective; however, some data suggest it may interact with antiplatelet medications and reduce their effectiveness and may slightly increase the risk of death.

    Vizuizi vya beta

    Because decreasing the heart’s workload also helps limit tissue damage, a beta-blocker is usually given to slow the heart rate. Slowing the rate enables the heart to work less hard and reduces the area of damaged tissue.

    Vizuizi vya njia ya kalsiamu

    Calcium channel blockers prevent blood vessels from narrowing (constricting) and can counter coronary artery spasm. All calcium channel blockers reduce blood pressure. Some of these medications, such as verapamil and diltiazem, may also reduce the heart rate. This effect can be useful to many people, especially those who cannot take beta-blockers or who do not get enough relief from nitrates.

    Vizuizi vya kimeng'enya kinachobadilisha angiotensini na vizuizi vya mapokezi vya angiotensini II

    Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) can reduce heart enlargement and increase the chance of survival for many people. Therefore, these medications are usually given in the first few days after a heart attack and prescribed indefinitely.

    Statins

    Statins have long been used to help prevent coronary artery disease, but they also have short-term benefit for people with an acute coronary syndrome. Doctors give a statin to people who are not already taking one.

    Dawa za kuzuia sahani za damu

    People who think they may be having a heart attack should chew an aspirin tablet immediately after calling an ambulance. If aspirin is not taken at home or given by emergency personnel, it is immediately given at the hospital. This therapy improves the chances of survival by reducing the size of the clot (if present) in the coronary artery. People may also be given other types of antiplatelet medications such as clopidogrel, ticlopidine, or ticagrelor taken by mouth, or glycoprotein IIb/IIIa inhibitors given by vein (intravenously).

    Dawa za kuyeyusha matone ya damu

    Clot-dissolving medications (thrombolytic medications) are given intravenously to open the arteries if percutaneous coronary interventions cannot be done within 90 minutes after the person arrives at the hospital.

    Dawa ya kuzuia usagaji wa damu

    Most people are also given an anticoagulant, such as heparin, to help prevent the formation of additional blood clots.

    Ranolazine na ivabradine

    Ranolazine and ivabradine are alternative therapies for people with angina that does not respond to the usual therapies (for example, nitrates or morphine).

    kizuizi cha PCSK-9

    This class of medication is used for people whose levels of low-density lipoprotein cholesterol (LDL-C), which is the "bad" cholesterol, is not at the target level. PCSK-9 inhibitors, such as alirocumab or evolocumab, are used alone or in combination with other lipid-lowering medications (for example, statins or ezetimibe) for the treatment of adults with primary hyperlipidemia, including familial hypercholesterolemia. They can be particularly useful for people who have difficulty tolerating the side effects of other medications that lower cholesterol levels.